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1. Introduction 
Continuous cell lines offer homogeneous popula- 
tions of differentiated cells to study the intracellular 
mechanisms involved in the hormonal control of spe- 
cific gene expression. Several 'GH' clonal strains derived 
from a transplantable rat pituitary tumor [ 1 ] have 
proved to be useful models for studying the secretion 
of two protein hormones, prolactin and growth hor- 
mone [2]. The 'GH' strains differ from each other in 
their functional characteristics such as basal evel of 
PRL production [3,4] and response to a physiological 
modulator as thyroliberin (TRH: pGlu-His-ProNH2) 
[5,6]. TRH induces a biphasic stimulating effect on 
PRL secretion by GH3 cells [7] as well as by another 
pituitary cell line, SDI [8]. Previous works allowed us 
to correlate the level of PRL production by these cells 
and their intracellular content of PRL mRNA,, as 
indirectly determined by either the PRL mRNA activ- 
ity of total cytoplasmic poly(A)-RNA in cell-free 
translation systems [9-12], or the molecular hybridi- 
zation of the specific sequences to complementary 
DNA probes [13]. 
Abbreviations: PRL, prolactin; GH, growth hormone; TRH, 
thyroliberin; mRNA, messenger RNA; poly(A), polyadenyl- 
ated; pGlu-His-ProNH2, pyroglutamyl-histidyl-proline 
amide; pGlu-His-Trp, pyroglutamyl-histidyl-tryptophane; 
EDTA, ethylene diamino tetraacetic acid; SDS, sodium 
dodecyl sulfate; poly(U), polyuridylic acid 
* Part of these results was reported in the Sixth Meeting of 
the International Society for Biochemical Endocrinology 
(1978) [31] 
However, the accumulation of a specific mRNA 
could be accounted for by an increased synthesis and/ 
or a decreased degradation. Thus, we have developed 
experiments to investigate PRL mRNA turnover in 
basal conditions and following TRH stimulation. For 
that purpose, we have used a subclone of the GH3 
line, GHaB6, selected in our laboratory for its high 
level of [3H] TRH binding sites [ 14]. Here, we provide 
direct evidence for the stimulation of the biosynthe- 
sis rate of the cytoplasmic PRL mRNA after TRH 
treatment of GH3B6 cells for 48 h. Moreover, this 
effect is specific for PRL mRNA since the synthesis 
of other poly(A)-mRNA species is only slightly or not 
at all increased*. These data strongly suggest that the 
increase of the PRL synthesis induced by TRH is 
mediated at least partially through a transcriptional 
effect and/or through the modulation of an early post- 
transcriptional step of the mRNA maturation. 
2. Materials and methods 
2.1. Cell culture 
GH3B6 cells were grown in monolayer cultures in 
Ham F1o medium supplemented with 15% horse serum 
and 2.5% fetal calf serum without antibiotics. Cells 
were plated at 2 × 106 cells/10 ml per 10 cm-petridish 
and precultured for 6 days. The medium was renewed 
each 2 days and TRH (27 nM) was added at the last 
medium change. In order to get optimum stimulation 
of PRL synthesis by TRH the medium was not changed 
during the 48 h incubation (not shown). As control, 
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we used a TRH analog (pGlu-His-Trp) inactive on 
PRL secretion [15]. 
2.2. RNA labelling and extraction 
The procedure was essentially that in [16]. To 
study the rate of synthesis of cytoplasmic RNAs, 
100/aCi [aH]uridine (30 Ci/mmol) per dish were in- 
troduced, without medium change, for the last 4 h of 
the 48 h incubation. 2-3 petri dishes were used per 
experimental group and the experiments were repeated 
3 times. 
At the end of the pulse-labelling the cells were 
washed once with Ham F~o medium and twice with 
phosphate-buffered saline. They were harvested and 
allowed to lyse for 10 min with gently stirring in a 
solution containing 0.14 M NaC1, 10 mM Tris-HC1 
(pH 7.5), 5 mM MgC12 and 0.1% NP 40 detergent. 
After centrifugation to remove the nuclei, cytoplasmic 
RNAs were extracted and deproteinized ~>3 times, 
with an equal volume of mixed chloroform-phenol- 
isoamyl alcohol (50:49:1, by vol.) in presence of 5 mM 
EDTA and 0.2% SDS. RNA was precipitated with 
2.5 vol. ethanol and stored at -30°C. 
rich RNAs were further purified by 2 cycles of oligo- 
(dT)-cellulose chromatography [19] and then ana- 
lysed on 15-30% sucrose gradient. Total and fractions 
of the poly(A)-RNAs were used to direct cell-free pro- 
tein synthesis in a reticulocyte lysate prepared as in 
[20]. Incorporation of [3SS]methionine into total 
translated proteins was measured by radioactivity of 
acid-insoluble material. 
2.5. Analysis of cell-free translation products 
The 'in vitro' translation products were analysed 
by electrophoresis onSDS-20% polyacrylamide slab 
gels and fluorography as in [21,22]. Furthermore, 
immunoprecipitations were made by the double anti- 
body procedure. Rabbit anti-rat PRL antiserum (pre- 
pared and kindly provided by D. Grouselle) was used 
as first antibody, and ovine anti-rabbit globulins anti- 
serum as the second one. Immunoprecipitates were 
pelleted through alayer of 1 M sucrose as in [23] and, 
after dissociation by heat (5 min at 100 °C) in presence 
of SDS, the proteins were further analysed by gel 
electrophoresis as above. 
2.3. RNA analysis 
Cytoplasmic RNA precipitate was dissolved in a 
solution containing 0.1 M NaC1, 10 mM Hepes 
(pH 7.5), 1 mM EDTA, 0.1% SDS and layered onto 
15-30% sucrose linear gradient. A minimum of 2 × 
107 cells were required for RNA analysis. After centrif- 
ugation in SW 41 Ti rotor at 27 000 rev./min for 17 h 
at 20°C, the absorbance prof'de at 254 nm was recorded 
and 0.8-1 ml fractions were collected. Radioactivity 
incorporated into total and each fraction of cytoplas- 
mic RNA was measured directly on aliquots (100 tA/ 
fraction). Most cytoplasmic mRNAs containing an 
adenosine-rich sequence (poly(A)-mRNAs) were selec- 
tively hybridized (500/A/fraction) onto poly(U)-glass 
fiber falters [17] and associated radioactivity was 
counted. 
2.4. Poly(A )-RNA directed cell-free protein synthesis 
GH3 B6 cells were cultivated and incubated for 48 h, 
in the presence or absence of TRH, as described. 
5 X 10s-109 cells were harvested and rapidly frozen 
in liquid nitrogen. They were homogenized by mixing 
in 3 M LiC1, 6 M urea [18] and RNA allowed to pre- 
cipitate overnight at 0--4°C. Then, RNA was pelleted 
by centrifugation at 20 000 × g for 30 rain and de- 
proteinized by phenol-chloroform extraction. Poly(A)- 
3. Results and discussion 
3.1. Effect of TRI-I on cytoplasmic RNA biosynthesis 
TRH treatment of GI-i3B6 cells for 48 h induced a
2-3-fold decrease of [3H]uridine incorporation into 
cytoplasmic RNAs, and yet had either no effect or a 
slight stimulating effect on incorporation i to poly- 
(A)-mRNAs (table 1). Moreover, when the radioactiv- 
ity incorporated into poly(A)-RNA was expressed 
as % of total cytoplasmic RNA, a 3-fold increase of 
this ratio was observed in TRH-treated cells as com- 
pared to control cells, whatever was the basal level of 
RNA synthesis in the experiment ( able 1). The 
decreased incorporation i to total cytoplasmic RNA 
resulted, at least in part, from a reduction of the uri- 
dine nucleotide intracellular pool after chronic treat- 
ment of the cells by TRH [24], and thus the increase 
of incorporation i to poly(A)-mRNA might be under- 
estimated. Therefore, these data suggest that TRH 
increases the rate of synthesis of poly(A)-mRNAs 
whereas apparently decreasing those of most cyto- 
plasmic RNAs. 
By sucrose gradient analysis, the radioactivity asso- 
ciated with total cytoplasmic RNA extracted from 
control cells displayed 2 major peaks corresponding 
to the ribosomal RNAs (18 S and 28 S) as observed 
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Table 1 
Incorporation of [3H]ufidine into total cytoplasmic RNA and poly(A)-RNA of 
GH3B 6 cells grown for 48 h in the absence (control) or presence of 27 nM TRH 
Treatment [3H]Uridine incorporation i to: Poly(A)-RNA 
(48 h) - -  % 
Total cyt. RNA Cyt. poly(A)-RNA cyt. -RNA 
(pmol/A 254 ) (fmol/A ~ s4) 
I. Control 6.55 111 1.69 
TRH 1.75 101 5.74 
II. Control " 11.55 59.3 0.51 
TRH 5.40 88.5 1.64 
Cells were labelled for the last 4 h and RNA were extracted as in section 2. Results 
of 2 independent expt. Radioactivity was expressed per absorbance unit (A:s4), 
corresponding to 40-50 ~g RNA 
by absorbance. No modification was induced by TRH 25 
treatment of  the cells (not shown). In contrast, the 
radioactivity associated with the poly(A)-mRNAs dis- 
played several peaks and shoulders which were modi- 
fied more or less depending on the duration of  the 
TRH treatment (not shown). When the cells were ~ 20 
treated for 48 h, the poly(A)-mRNAs displayed a
5-fold increase of the peak at ~12-13  S, whereas the ~,  
other peaks (22-30  S) decreased more or less (fig.l). 
Thus the ratio of  incorporated radioactivity into poly- ~,z 
(A)-RNA vs total cytoplasmic RNA was 10-15-fold E is 
I 
increased for the 12-13 S peak whereas it was not 
modified or at the best increased 2 times for the other ~£ 
fractions of  the gradient (fig.2). Treatment of  GH3B6 o e~ 
cells (48 h) with pG lu -H is -T rp  (27 nM) did not sig- .o 10 
E nificant modify the incorporation of [3H]uridine 
into the cytoplasmic poly(A)-RNAs as compared to 
control cells (fig.2), in keeping with its failure to 
increase the PRL secretion. Thus, these results point ~ s 
out the ability of  the TRH peptide to stimulate spe- " 
cifically the rate of biosynthesis of the '12 -13  S' 
poly(A)-RNA. Indeed, the slight enhancement of
the relative production rate of  other poly(A)-mRNA 
species (22-30  S) resulted from the lower inhibition 0 
of  their biosynthesis as compared to that of  cytoplas- 
mic RNA (table 1). 
3.2. Characterization f the '12-13 S' poly(A )-RNA 
Total poly(A)-RNA extracted from either control 
or TRH-treated cells directed the synthesis 'in vitro' 
of  the same many proteins, except one protein syn- 
thesized in greater amount after TRH incubation of 
the cells (fig.3A). This protein has M r ~> 25 000 as 
A 
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Fig.1. Sedimentation a alysis of neosynthesized cytoplasmic 
poly(A)-mRNAs in GH~B~ cells grown for 48 h in the absence 
(e - -o )  or presence of 27 nM TRH (i. • .,). Ceils were label- 
led with [3H]uridine for the last 4 h and RNA was extracted 
and analysed on 15 -30% linear sucrose gradient [4 A 2s4 units 
of total cytoplasmic RNA/gradient] as in section 2. The radio- 
activity of each poly(A)-RNA fraction was expressed as % of 
total radioactivity onto the gradient. 
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These data are in agreement with previous work 
providing evidence that messenger activity coding for 
PRL lies in a specific mRNA of ~11-13  S purified 
from GH3 cells [27] as well as from rat pituitaries 
[28,29]. Moreover, they provide a direct demonstra- 
tion of the stimulation of PRL mRNA biosynthesis, 
and show that the TRH4nduced shift concerns pre- 
Fig.2. Relative rate of neosynthesis ofpoly(A)-mRNAs vs 
total cytoplasmic RNAs in each gradient fraction of RNA 
isolated from GH3B 6 ceils grown for 48 h incontrol medium 
(e - -e ) ,  in medium containing either 27 nM TRH (o. • .<>) or 
27 nM TRH analog (m---m) as in section 2. Circled numbers 
correspond to poly(A)-mRNA fractions assayed for their trans- 
lational activity in fig.3. 
compared to size markers. Moreover, this protein was 
the only one to be immunoprecipitated withthe anti- 
rat PRL-specific antiserum (fig.3B). Therefore, it can 
be identified as the larger precursor form of PRL, the 
preprolactin (pPRL) already described as the inter- 
mediate nascent polypeptide during the biosynthesis 
of PRL in intact cells [11,25] and, as the initial pro- 
duct of cell-free translation [9,26,27]. 
The 'in vitro' translational activity has been assayed 
for every fractions of cytoplasmic RNAs separated by 
sucrose density gradient. Among the several gradient 
fractions of the poly(A)-RNAs extracted from TRH- 
treated ceils only the fractions corresponding to the 
12-13 S peak (fig.3A,B) displayed the capacity to 
direct the synthesis of pPRL. The homologous frac- 
tions of the poly(A)-RNAs extracted from control 
cells displayed less capacity of pPRL synthesis (fig. 
3A,B). 
Fig.3(A). Analysis otcell-tree translation products: total and 
fractions of poly(A)-mRNA were used to irect cell-free pro- 
tein synthesis in a reticulocyte lysate system. The translation 
products were analysed using 20% acrylamide slab gels in the 
presence of SDS and fluorographed (see section 2). Products 
of translation directed by: lane 0, residual endogenous RNA; 
lane C, total poly(A)-RNA from control cells; lane T, total 
poly(A)-RNA from TRH-treated cells: lanes 4-10,gradient 
fractions 4-10 (see fig.2) of poly(A)-RNA from TRH-treated 
cells; lane 8", gradient fraction f poly(A)-RNA from control 
cells, homologous to the lane 8 fraction of TRH-treated cells; 
lane M, total poly(A)-RNA from myeloma cells: a, a-immuno- 
globulin chain (M r 60 000); ac, actin (M r 43 000; and k, k-im- 
munoglobulin chain (M r 25 000), used as size markers. 
Fig.3(B). The translation products were submitted to im- 
munoprecipitation using a highly specific anti-rat prolactin 
antiserum. Immunoprecipitates were pelleted through a layer 
of 1 M sucrose, heat-dissociated in presence of SDS, and pro- 
teins were analysed by gel electrophoresis as above. The lanes 
correspond to those in the legend (A). 
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ferential ly this mRNA species. The TRH-mediated 
regulation of  PRL  biosynthesis through the control  of  
its specific mRNA product ion most l ikely represents 
the primary step in hormonal  stimulation. This may 
take place at a transcriptional level or at one of  the 
first post-transcriptional events setting in the nucleus, 
and thus may be related to the presence, already 
shown, o f  nuclear specific binding sites for [3H] TRH 
in GH 3 cells [30]. 
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